ImmunoGen Inc (IMGN) Stock Analyst Earnings Estimates
NASDAQ:IMGN - Nasdaq - US45253H1014 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 132.3M 60.75% | 69.9M -47.17% | 108.8M 55.65% | 384.16M 253.09% | 560.86M 46.00% | 794.2M 41.60% | 1.028B 29.44% | 1.22B 18.68% | 1.321B 8.28% | 1.302B -1.44% | 1.41B 8.29% | |
| EBITDA YoY % growth | -18.8M 71.84% | -123.08M -554.68% | -219.12M -78.03% | -133.62M 39.02% | -82.62M 38.17% | 223.44M 370.44% | 483.45M 116.37% | 634.43M 31.23% | N/A | N/A | N/A | |
| EBIT YoY % growth | -20.9M 70.48% | -125.1M -498.56% | -220.9M -76.58% | 15.273M 106.91% | 116.72M 664.22% | 277.81M 138.01% | 466.61M 67.96% | 615.47M 31.90% | 734.1M 19.27% | 700.5M -4.58% | 785.76M 12.17% | |
| Operating Margin | -15.80% | -178.97% | -203.03% | 3.98% | 20.81% | 34.98% | 45.39% | 50.45% | 55.57% | 53.80% | 55.73% | |
| EPS YoY % growth | -0.28 60.56% | -0.67 -139.29% | -0.88 -31.34% | 0.08 108.78% | 0.38 396.25% | 0.88 128.46% | 1.44 64.94% | 1.90 31.62% | 2.13 12.17% | 1.97 -7.66% | 2.12 7.77% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.13 157.18% | 0.04 123.91% | 0.09 527.13% | 0.11 10.74% | 0.14 3.05% | 0.12 220.00% | 0.14 67.16% | 0.20 84.21% | 0.20 50.53% | 0.22 83.33% | 0.26 78.57% | 0.28 35.00% |
| Revenue Q2Q % growth | 132.82M 222.38% | 126.87M 154.25% | 138.43M 66.38% | 141.89M 25.12% | 155.95M 17.41% | 156.57M 23.41% | 170.71M 23.32% | 194.75M 37.25% | 210M 34.66% | 215.22M 37.46% | 227.46M 33.24% | 232.56M 19.41% |
| EBITDA Q2Q % growth | 30.753M 153.19% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 38.124M 163.97% | 29.329M 169.17% | 39.667M 1,044.45% | 44.209M 70.03% | 50.272M 31.86% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 0.10 132.26% | 0.05 | 0.05 | 119.72% |
| Q2 2023 Q2Q % growth | -0.02 91.67% | -0.14 | 0.12 | 85.91% |
| Q1 2023 Q2Q % growth | -0.16 -60.00% | -0.25 | 0.09 | 37.05% |
| Q4 2022 Q2Q % growth | -0.23 -35.29% | -0.30 | 0.07 | 23.99% |
| Q3 2022 Q2Q % growth | -0.31 -72.22% | -0.26 | -0.05 | -19.40% |
| Q2 2022 Q2Q % growth | -0.24 -60.00% | -0.22 | -0.02 | -10.99% |
| Q1 2022 Q2Q % growth | -0.10 41.18% | -0.22 | 0.12 | 53.54% |
| Q4 2021 Q2Q % growth | -0.17 -206.25% | -1.74 | 1.57 | 90.24% |
| Q3 2021 Q2Q % growth | -0.18 -38.46% | -0.19 | 0.01 | 4.32% |
| Q2 2021 Q2Q % growth | -0.15 -7.14% | -0.19 | 0.04 | 19.30% |
| Q1 2021 Q2Q % growth | -0.17 | -0.19 | 0.02 | 11.11% |
| Q4 2020 Q2Q % growth | 0.16 433.33% | -0.08 | 0.24 | 293.66% |
| Q3 2020 Q2Q % growth | -0.13 13.33% | -0.18 | 0.05 | 29.59% |
| Q2 2020 Q2Q % growth | -0.14 51.72% | -0.17 | 0.03 | 18.94% |
| Q1 2020 Q2Q % growth | -0.17 43.33% | -0.16 | -0.01 | -8.70% |
| Q4 2019 Q2Q % growth | 0.03 | -0.05 | 0.08 | 161.79% |
| Q3 2019 Q2Q % growth | -0.15 | -0.19 | 0.04 | 19.02% |
| Q2 2019 Q2Q % growth | -0.29 | -0.34 | 0.05 | 13.69% |
| Q1 2019 Q2Q % growth | -0.30 | -0.20 | -0.10 | -47.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 113.4M 636.36% | 108.54M | 4.86M | 4.48% |
| Q2 2023 Q2Q % growth | 83.2M 485.92% | 49.316M | 33.884M | 68.71% |
| Q1 2023 Q2Q % growth | 49.9M 30.97% | 20.881M | 29.019M | 138.97% |
| Q4 2022 Q2Q % growth | 41.2M 47.14% | 17.597M | 23.603M | 134.13% |
| Q3 2022 Q2Q % growth | 15.4M 67.39% | 12.725M | 2.675M | 21.02% |
| Q2 2022 Q2Q % growth | 14.2M -15.98% | 16.499M | -2.299M | -13.93% |
| Q1 2022 Q2Q % growth | 38.1M 142.68% | 21.903M | 16.197M | 73.95% |
| Q4 2021 Q2Q % growth | 28M -67.37% | 26.162M | 1.838M | 7.03% |
| Q3 2021 Q2Q % growth | 9.2M -49.45% | 19.408M | -10.208M | -52.60% |
| Q2 2021 Q2Q % growth | 16.9M 12.67% | 19.3M | -2.4M | -12.44% |
| Q1 2021 Q2Q % growth | 15.7M 18.05% | 18.082M | -2.382M | -13.17% |
| Q4 2020 Q2Q % growth | 85.8M 91.09% | 41.644M | 44.156M | 106.03% |
| Q3 2020 Q2Q % growth | 18.2M 36.84% | 15.665M | 2.535M | 16.18% |
| Q2 2020 Q2Q % growth | 15M -3.23% | 14.883M | 117K | 0.79% |
| Q1 2020 Q2Q % growth | 13.3M 54.65% | 15.241M | -1.941M | -12.74% |
| Q4 2019 Q2Q % growth | 44.9M | 29.912M | 14.988M | 50.11% |
| Q3 2019 Q2Q % growth | 13.3M | 10.075M | 3.225M | 32.01% |
| Q2 2019 Q2Q % growth | 15.5M | 9.666M | 5.834M | 60.36% |
| Q1 2019 Q2Q % growth | 8.6M | 10.806M | -2.206M | -20.41% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 10.27% | 6.14% | 223.03% |
| Revenue | 0% | 2.12% | 0.2% | 7.31% |